Interested in vaccine clinical trials? 7 November 2012 / By Freya Smale / Regulation and Policy / 0 comments
Reinventing the vaccine clinical trial under modern scientific pressures 6 November 2012 / By Freya Smale / Regulation and Policy / 0 comments
Presentation download: the Quality by Design concept 29 October 2012 / By Freya Smale / Regulation and Policy / 0 comments
What are the new regulatory considerations for vaccine manufacturing? 24 October 2012 / By Freya Smale / Regulation and Policy / 1 comment
Live event feed: Isabel De la Mata 17 October 2012 / By Freya Smale / Regulation and Policy / 0 comments
Live event feed: Dr Pierre Morgan 16 October 2012 / By Freya Smale / Regulation and Policy / 0 comments
Live event feed: Professor Daniel Floret 16 October 2012 / By Freya Smale / Regulation and Policy / 0 comments
US Government impact on vaccine manufacturing 11 October 2012 / By Freya Smale / Regulation and Policy / 0 comments
Regulatory Perspective for Plant-based Vaccines 3 October 2012 / By Freya Smale / Regulation and Policy / 0 comments
Guest blog by EpiVax: Who would want “vaccines on demand?” Ask the mother of a child in Cambodia. 25 September 2012 / By Caroline Hornby / Emerging Markets, Flu, Partnering and Corporate strategy, Regulation and Policy, Therapeutic Vaccines / 0 comments
